Topic: Finland

Cervical cancer vaccines may cut need for screening

LONDON (Reuters) - Using GlaxoSmithKline's Cervarix vaccine to protect girls against the HPV virus that causes cervical cancer is so effective that health authorities could reduce the need for later cervical screening, scientists said on Wednesday.Researchers from Finland and the United States ...

THE HISTORY OF PAPILLOMAVIRUS RESEARCH

The article discusses the history of papillomavirus (HPV) research. It states that the dramatic progress in all areas of HPV research in the 1980s was due to the development of molecular cloning and related techniques. S7-S41 INVITED SPEAKERS THE HISTORY OF PAPILLOMAVIRUS ...
In boys aged 10 to 18, Cervarix -- a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine -- is immunogenic and well tolerated, researchers report in the January issue of the Journal of Adolescent Health.. Tiina Petaja, M.D., of the University of Tampere in Tampere, ...